Alto Neuroscience Inc.
ANRO | NYSE
$30.41
-$0.22 (-0.72%)
Sep 22, 2026, 11:55 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 |
|---|---|---|---|---|---|
PE Ratio | -8.13 | -1.69 | -15.33 | -19.17 | -57.50 |
PEG Ratio | 0.66 | -0.02 | -0.61 | -0.10 | n/a |
PS Ratio | n/a | n/a | n/a | n/a | 2.52K |
PB Ratio | 3.40 | 0.69 | -7.76 | -13.78 | -42.43 |
P/FCF Ratio | -9.92 | -2.10 | -16.41 | -25.06 | -53.25 |
P/OCF Ratio | -9.92 | -2.19 | -16.64 | -25.96 | -57.16 |
OCF/S Ratio | n/a | n/a | n/a | n/a | -4.41K |
Debt / Equity Ratio | 0.03 | 0.11 | -0.14 | -2.14 | -3.06 |
Quick Ratio | 15.69 | 16.92 | 15.22 | 8.85 | 15.30 |
Current Ratio | 15.69 | 16.92 | 15.22 | 8.85 | 15.30 |
Asset Turnover | n/a | n/a | n/a | n/a | 0.01 |
Interest Coverage | -26.88 | 49.90 | -27.60 | n/a | n/a |
Return on Equity | -41.84% | -40.56% | 50.65% | 72.15% | 73.63% |
Return on Assets | -34.24% | -34.60% | -41.91% | -54.49% | -31.91% |
Return on Invested Capital | -38.15% | -40.74% | -46.60% | -64.05% | -44.68% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | 30.95% |
Net Profit Margin | n/a | n/a | n/a | n/a | -4.37K% |
Pretax Profit Margin | n/a | n/a | n/a | n/a | -4.37K% |
Operating Profit Margin | n/a | n/a | n/a | n/a | -5.74K% |
FCF Margin | n/a | n/a | n/a | n/a | -4.73K% |
EBITDA Margin | n/a | n/a | n/a | n/a | -4.31K% |
Add to Watchlist
Select watchlists to add or remove ANRO